COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03421496
Recruitment Status : Terminated (The study was terminated due to slow enrollment and failure to identify adequate patients that met entry criteria.)
First Posted : February 5, 2018
Last Update Posted : November 13, 2020
Information provided by (Responsible Party):
Benuvia Therapeutics Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 29, 2019
Actual Study Completion Date : May 29, 2019